- Trials with a EudraCT protocol (185)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
185 result(s) found for: Iron Deficiency.
Displaying page 2 of 10.
EudraCT Number: 2007-000764-25 | Sponsor Protocol Number: P-CHF-01 | Start Date*: 2007-05-10 | ||||||||||||||||
Sponsor Name:Pharmacosmos A/S | ||||||||||||||||||
Full Title: A non-comparative open-label study of Iron Oligosaccharide in CHF patients with iron deficiency (either absolute or functional) anaemia and a need for parenteral iron. | ||||||||||||||||||
Medical condition: Patients with anaemia and who have a need for parenteral iron due to either absolute or functional iron deficiency anaemia will be included. Patients may receive concomitant Erythropoeisis Stimulat... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-000078-31 | Sponsor Protocol Number: ST10-01-305 | Start Date*: 2025-04-09 | |||||||||||
Sponsor Name:Shield TX (UK) Ltd. | |||||||||||||
Full Title: Randomised, open-label, active-controlled, multicentre, comparative study to evaluate the safety and efficacy of ferric maltol (iron(III)-maltol complex) (ST10) oral suspension compared to ferrous ... | |||||||||||||
Medical condition: Iron deficiency anaemia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012544-16 | Sponsor Protocol Number: P-Monofer-IBD-01 | Start Date*: 2009-12-31 | ||||||||||||||||
Sponsor Name:Pharmacosmos A/S | ||||||||||||||||||
Full Title: A phase III, randomized, comparative, open-label study of intravenous iron oligosaccharide (Monofer®) administered by infusions or repeated bolus injections in comparison with oral iron sulphate in... | ||||||||||||||||||
Medical condition: Inflammatory bowel disease subjects with iron deficiency anaemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) DK (Completed) AT (Completed) HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-005100-26 | Sponsor Protocol Number: ORION-PH-1 | Start Date*: 2017-10-09 | ||||||||||||||||
Sponsor Name:Hannover Medical School | ||||||||||||||||||
Full Title: A pilot Study to explore safety, tolerability and efficacy of ORal IrON supplementation with ferric maltol in treating iron deficiency in patients with pulmonary hypertension and iron deficiency an... | ||||||||||||||||||
Medical condition: Patients with iron deficiency anemia and pulmonary hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001529-28 | Sponsor Protocol Number: P-Monofer-BD-02 | Start Date*: 2012-06-13 | |||||||||||
Sponsor Name:Pharmacosmos A/S | |||||||||||||
Full Title: A Randomized, Prospective, Double-Blind, Comparative Placebo-Controlled Study of Intravenous Iron Isomaltoside 1000 (Monofer®) administered by Infusions to Iron-Deficient Blood Donors | |||||||||||||
Medical condition: Female first-time bloddonors with iron deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000158-21 | Sponsor Protocol Number: 740220 | Start Date*: 2017-04-13 | ||||||||||||||||
Sponsor Name:Karolinska Institutet | ||||||||||||||||||
Full Title: Ferroglycine Sulfate Absorption in patients with Heart Failure and Iron Deficency: an interventional before and after study. | ||||||||||||||||||
Medical condition: Chronic Heart Failure with Iron Deficiency | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-001389-12 | Sponsor Protocol Number: PICS1.0 | Start Date*: 2020-10-29 | ||||||||||||||||
Sponsor Name:Aarhus University Hospital | ||||||||||||||||||
Full Title: The Postoperative Iron in Cardiac Surgery (PICS-) trial: A randomised clinical trial comparing the efficacy of single-, high-dose intravenous iron and oral iron for the treatment of anaemia followi... | ||||||||||||||||||
Medical condition: Anaemia following cardiac surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-000209-22 | Sponsor Protocol Number: 12GA029 | Start Date*: 2013-06-07 | |||||||||||
Sponsor Name:Research and Development Nottingham University Hospital | |||||||||||||
Full Title: A pilot study to assess the efficacy of intravenous iron isomaltoside 1000 (Monofer®) in the management of anaemia associated with the palliative management of upper gastrointestinal adenocarcinoma | |||||||||||||
Medical condition: The medical condition to be investigated is anaemia in patients with oesophageal or gastric cancer planned to undergo palliative chemotherapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003069-28 | Sponsor Protocol Number: SWB0115 | Start Date*: 2015-10-23 | |||||||||||
Sponsor Name:Serumwerk Bernburg AG | |||||||||||||
Full Title: An open label trial evaluating the pharmacokinetics and safety of an intravenously administered single dose of Feramyl® 200 mg, 500 mg or 1500 mg vs. Ferinject® 500 mg in patients suffering from an... | |||||||||||||
Medical condition: Post-operative iron defieciency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002192-10 | Sponsor Protocol Number: ST10-01-103 | Start Date*: 2017-02-16 | ||||||||||||||||
Sponsor Name:Shield TX (UK) Limited | ||||||||||||||||||
Full Title: A phase 1, open label, randomised, repeat dose, parallel group study to evaluate the pharmacokinetics, safety and tolerability of ferric maltol at the three dosage levels in paediatric subjects age... | ||||||||||||||||||
Medical condition: Iron deficiency (with or without anaemia) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-004979-13 | Sponsor Protocol Number: 2012-496 | Start Date*: 2014-01-29 | ||||||||||||||||
Sponsor Name:Rigshospitalet, 2032 | ||||||||||||||||||
Full Title: Treatment of Preoperative Anaemia in Patients with Urogenital Cancer: A Randomised Double-Blind Placebo-Controlled Study of Intravenous Iron Isomaltide 1000 Monofer© versus Saline | ||||||||||||||||||
Medical condition: Iron deficiency anaemia and anaemia of chronic disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015630-30 | Sponsor Protocol Number: FER-CKD-201 | Start Date*: 2010-08-11 | |||||||||||
Sponsor Name:AMAG Pharmaceuticals, Inc. | |||||||||||||
Full Title: Ferumoxytol Compared to Iron Sucrose Trial (FIRST): A Randomized, Multicenter, Trial of Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects with Chron... | |||||||||||||
Medical condition: Iron deficiency anemia in subjects with Chronic kidney disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000765-37 | Sponsor Protocol Number: P-CKD-01 | Start Date*: 2007-05-10 | |||||||||||||||||||||
Sponsor Name:Pharmacosmos A/S | |||||||||||||||||||||||
Full Title: A non-comparative open-label study of Iron Oligosaccharide in Chronic Kidney Disease patients with a need for parenteral iron | |||||||||||||||||||||||
Medical condition: Patients with Chronic kidney disease who are in pre-dialysis or undergoing dialysis (either Peritoneal Dialysis or Haemodialysis), who may be treated with erythropoeisis stimulating agents and have... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: SE (Completed) DK (Completed) GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003121-94 | Sponsor Protocol Number: P-Monofer-IBD-02 | Start Date*: 2011-12-14 | |||||||||||
Sponsor Name:Pharmacosmos A/S | |||||||||||||
Full Title: A Prospective, Non-controlled, Safety Study of Intravenous Iron Isomaltoside 1000 (Monofer®) administered by a High Dosing Regimen in Subjects with Inflammatory Bowel Disease (PROMISE) | |||||||||||||
Medical condition: Inflammatory Bowel Disease (IBD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) SE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001503-26 | Sponsor Protocol Number: FER-CARS-03 | Start Date*: 2008-10-17 | ||||||||||||||||
Sponsor Name:Vifor Pharma - Vifor (International) AG | ||||||||||||||||||
Full Title: EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac function in patients with iron deficiencY and chronic Heart Failure (EFFICACY-HF) | ||||||||||||||||||
Medical condition: Ambulatory patients with stable symptomatic chronic CHF (congestive heart failure) and iron deficiency. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) DE (Completed) NL (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002786-35 | Sponsor Protocol Number: 12/0246 | Start Date*: 2012-11-05 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: A randomised double-blind controlled phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose with placebo in patients with anaemia undergoing major open abdominal su... | |||||||||||||
Medical condition: Anaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014016-35 | Sponsor Protocol Number: 2008/258 | Start Date*: 2009-09-17 | |||||||||||||||||||||
Sponsor Name:Afdeling V, Aarhus Sygehus | |||||||||||||||||||||||
Full Title: Jernsubstitution efter øvre mavetarmblødning Undersøgelse af effekten af jernbehandling peroralt (Ferro Duretter® ) eller Intravenøst (Ferinject®) i 3 måneder efter udskrivelse versus ingen jernbe... | |||||||||||||||||||||||
Medical condition: Patienter, der har haft akut øvre gastrointestinal blødning med efterfølgende endoskopisk intervention og har nedsat hæmoglobinniveau (mindre end nedre referenceinterval værdi) ved udskrivelsestids... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-000894-16 | Sponsor Protocol Number: NL79105.058.22 | Start Date*: 2022-05-04 | |||||||||||||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||||||||||||
Full Title: Predicting Response to Iron Supplementation in Patients with active Inflammatory Bowel Disease | |||||||||||||||||||||||
Medical condition: Inflammatory Bowel Disease | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003140-71 | Sponsor Protocol Number: RMFPC-22 | Start Date*: 2020-08-25 | |||||||||||
Sponsor Name:Rockwell Medical, Inc. | |||||||||||||
Full Title: Hemoglobin maintenance in pediatric ESRD patients by ferric pyrophosphate citrate (FPC) | |||||||||||||
Medical condition: Iron deficiency anaemia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016727-53 | Sponsor Protocol Number: P-Monofer-CIA-01 | Start Date*: 2010-04-12 | |||||||||||
Sponsor Name:Pharmacosmos A/S | |||||||||||||
Full Title: A phase III, randomized, open-label study of intravenous iron isomaltoside 1000 (Monofer®) as mono therapy (without erythropoeisis stimulating agents) in comparison with oral iron sulfate in subjec... | |||||||||||||
Medical condition: non-myeloid malignancies associated with chemotherapy induced anaemia (CIA). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) GB (Completed) SE (Completed) DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
